These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 459731)

  • 21. Schedule in Cf-252 neutron brachytherapy: complications after delayed implant therapy for cervical cancer in a phase II trial.
    Maruyama Y; van Nagell JR; Yoneda J; Gallion HH; DePriest P; Feola JM; Wierzbicki J
    Am J Clin Oncol; 1993 Apr; 16(2):168-74. PubMed ID: 8452113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [252Cf in combined radiation therapy of cancer of the uterine cervix].
    Pozmogov AI; Abdullaev VD; Letov VN; Sul'kin AG; Skliar MN
    Med Radiol (Mosk); 1976 Dec; 21(12):53-6. PubMed ID: 1025419
    [No Abstract]   [Full Text] [Related]  

  • 23. Early changes in flow cytometric DNA profiles induced by californium-252 neutron brachytherapy in squamocellular carcinomas of the uterine cervix.
    Tacev T; Zaloudík J; Janáková L; Vagunda V
    Neoplasma; 1998; 45(2):96-101. PubMed ID: 9687890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human cervical cancer clearance after 252Cf neutron brachytherapy versus conventional photon brachytherapy.
    Maruyama Y; Muir W
    Am J Clin Oncol; 1984 Aug; 7(4):347-52. PubMed ID: 6741864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of conditions of radiation protection of medical personnel during intracavitary neutron therapy of cervical cancer].
    Kostromina KN; Korenkov IP; Bocharov AL; Gladkikh NN
    Med Radiol (Mosk); 1991; 36(10):50-2. PubMed ID: 1943558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutron and gamma dose distribution for tandem, tandem and ovoid and plaque for intracavitary 252Cf therapy of cervix carcinoma.
    Maruyama Y; Tai DL; Beach JL
    Radiat Med; 1983; 1(3):230-6. PubMed ID: 6390538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic dosimetry for Cf-252 neutron brachytherapy of pelvic cancer.
    Maruyama Y; Beach JL; Hazle J; Ashtari M; Schroy CB; Olson MH
    Int J Radiat Oncol Biol Phys; 1985 May; 11(5):927-35. PubMed ID: 3921501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interstitial neutron therapy using flexible 252Cf sources].
    Vtiurin BM; Medvedev VS; Ivanov VN; Elisiutin GP; Petrovskaia GA
    Med Radiol (Mosk); 1984 Jun; 29(6):7-16. PubMed ID: 6738328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot study on neutron therapy. Part 1: The applicability of neutron therapy.
    Eichhorn HJ
    Radiobiol Radiother (Berl); 1981; 22(3):262-92. PubMed ID: 7302184
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dosimetric prerequisites for the intracavitary neutron therapy of cervical cancer based on the simple afterloading principle].
    Kostromina KN; Elisiutin GP; Komar VIa; Fadeeva MA; Nikologorskiĭ AV
    Med Radiol (Mosk); 1977 Oct; 22(10):78-80. PubMed ID: 916846
    [No Abstract]   [Full Text] [Related]  

  • 31. Biologically effective doses from californium-252 intracavitary applications.
    Iyer PS
    Strahlentherapie; 1975 Feb; 149(2):185-7. PubMed ID: 806142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compound dual radiation action theory for 252Cf brachytherapy.
    Wang CK; Zhang X
    Radiat Prot Dosimetry; 2004; 110(1-4):801-6. PubMed ID: 15353749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neutron dosimetry in a model of the body's inhomogeneities using the TLD-300 detector].
    Pöller F; Rassow J
    Strahlenther Onkol; 1990 Jun; 166(6):435-9. PubMed ID: 2363107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential of californium-252 in radiotherapy. Preclinical measurements in physics and radiobiology.
    Hall EJ; Rossi H
    Br J Radiol; 1975 Oct; 48(574):777-90. PubMed ID: 811295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with californium-252 (second report).
    Tsuya A; Kaneta K; Sugiyama T; Onai Y; Irifune T; Tomaru T; Uchida M; Kamata S; Tsuchida Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Apr; 39(4):370-89. PubMed ID: 482062
    [No Abstract]   [Full Text] [Related]  

  • 36. [Method of neutron contact therapy using 252Cf sources].
    Vtiurin BM; Ivanov VN; Nikitenko VA; Ivanova LF; Komar VIa
    Med Radiol (Mosk); 1981 May; 26(5):7-13. PubMed ID: 7242287
    [No Abstract]   [Full Text] [Related]  

  • 37. Californium-252: isotope for modern radiotherapy of cervix, uterine and vaginal carcinomas.
    Maruyama Y; Beach JL; van Nagell JR
    Strahlentherapie; 1984 Jun; 160(6):373-81. PubMed ID: 6464041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dosimetry in contact therapy with 252Cf irradiation].
    Elisiutin GP; Komar VIa
    Med Radiol (Mosk); 1977 Oct; 22(10):54-9. PubMed ID: 916842
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sensitive, biological dosimetry in vivo of fast neutron using an external measuring technic (125-iododeoxyuridine)].
    Zamboglou N; Mühlensiepen H; Porschen W; Feinendegen LE
    Strahlenschutz Forsch Prax; 1978; 19():73-7. PubMed ID: 746578
    [No Abstract]   [Full Text] [Related]  

  • 40. Dosimetry for 252Cf neutron emitting brachytherapy sources: protocol, measurements, and calculations.
    Rivard MJ
    Med Phys; 1999 Aug; 26(8):1503-14. PubMed ID: 10501050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.